Objectives: To assess a new application of artificial intelligence for real‐time detection of laryngeal squamous cell carcinoma (LSCC) in both white light (WL) and narrow‐band imaging (NBI) videolaryngoscopies based on the You‐Only‐Look‐Once (YOLO) deep learning convolutional neural network (CNN).Study Design: Experimental study with retrospective data.Methods: Recorded videos of LSCC were retrospectively collected from in‐office transnasal videoendoscopies and intraoperative rigid endoscopies. LSCC videoframes were extracted for training, validation, and testing of various YOLO models. Different techniques were used to enhance the image analysis: contrast limited adaptive histogram equalization, data augmentation techniques, and test time augmentation (TTA). The best‐performing model was used to assess the automatic detection of LSCC in six videolaryngoscopies.Results: Two hundred and nineteen patients were retrospectively enrolled. A total of 624 LSCC videoframes were extracted. The YOLO models were trained after random distribution of images into a training set (82.6%), validation set (8.2%), and testing set (9.2%). Among the various models, the ensemble algorithm (YOLOv5s with YOLOv5m—TTA) achieved the best LSCC detection results, with performance metrics in par with the results reported by other state‐of‐the‐art detection models: 0.66 Precision (positive predicted value), 0.62 Recall (sensitivity), and 0.63 mean Average Precision at 0.5 intersection over union. Tests on the six videolaryngoscopies demonstrated an average computation time per videoframe of 0.026 seconds. Three demonstration videos are provided.Conclusion: This study identified a suitable CNN model for LSCC detection in WL and NBI videolaryngoscopies. Detection performances are highly promising. The limited complexity and quick computational times for LSCC detection make this model ideal for real‐time processing.Level of Evidence: 3 Laryngoscope, 132:1798–1806, 2022

The efficacy mepolizumab in severe asthmatic patients is proven in the literature. Primarily to study the effect of mepolizumab on exacerbations, steroid dependence, and the continuation of efficacy in the long term. Secondarily to evaluate the effect of the drug on nasal polyps. Analyzing data from SANI (Severe Asthma Network Italy) clinics, we observed severe asthmatic patients treated with mepolizumab 100 mg/4 weeks, for a period of 3 years. 157 patients were observed. Exacerbations were reduced from the first year (−84.6%) and progressively to 90 and 95% in the second and third ones. Steroid-dependent patients decreased from 54% to 21% and subsequently to 11% in the second year and 6% in the third year. Patients with concomitant nasal polyps, assessed by SNOT-22, showed a 49% reduction in value from baseline to the third year. The study demonstrated the long-term efficacy of mepolizumab in a real-life setting.

Laryngeal Cancer (LC) constitutes approximately one third of head and neck cancers. Detecting early-stage lesions in this anatomical region is crucial for achieving a high survival rate. However, it poses significant diagnostic challenges owing to the varied appearance of lesions and the need for precise characterization for appropriate clinical management. Conventional diagnostic approaches rely heavily on endoscopic examination, which often requires expert interpretation and may be limited by subjective assessment. Deep learning (DL) approaches offer promising opportunities for automating lesion detection, but their efficacy in handling multi-modal imaging data and accurately localizing small lesions remains a subject of investigation. Furthermore, the clinical domain may largely benefit from the deployment of efficient DL methods that can ensure equitable access to advanced technologies, regardless of the availability of resources that can often be limited. In this study, a DL-based approach, named SRE-YOLO, was introduced to provide real-time assistance to less-experienced personnel during laryngeal assessment, by automatically detecting lesions at different scales from endoscopic White Light (WL) and Narrow-Band Imaging (NBI) images. During the training, the SRE-YOLO integrates a YOLOv8 nano (YOLOv8n) baseline with a Super-Resolution (SR) branch to enhance lesion detection. This last component is decoupled during inference to preserve the low computational demand of the YOLOv8n baseline. The evaluation was conducted on a multi-center dataset, encompassing diverse laryngeal pathologies and acquisition modalities. The SRE-YOLO method improved the Average Precision (AP_@IoU=0.5) in lesion detection by 5% with respect to the YOLOv8n baseline, while maintaining the inference speed of 58.8 Frames Per Second (FPS). Comparative analyses against state-of-the-art DL methods highlighted the efficacy of the SRE-YOLO approach in balancing detection accuracy, computational efficiency, and real-time applicability. This research underscores the potential of SRE-YOLO in developing efficient DL-driven decision support systems for real-time detection of laryngeal lesions at different scales from both WL and NBI endoscopic data.